Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2019 Financial Results

Fulcrum Therapeutics Inc. (FULC) Tops Q4 EPS by 12c

March 5, 2020 7:05 AM EST

Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q4 EPS of ($0.71), $0.12 better than the analyst estimate of ($0.83).

We made important progress at a rapid pace in 2019 as we transitioned from a private, discovery company into a public, clinical-stage company, said Robert J. Gould, president and chief... More